| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/26/2007 | EP1868652A2 Method for shielding functional sites or epitopes on proteins |
| 12/26/2007 | EP1868637A1 Mechano growth factor peptides and their use |
| 12/26/2007 | EP1722819B1 Method for solubilising peptide mixtures |
| 12/26/2007 | EP1615663B1 Agent for treating leishmania infections |
| 12/26/2007 | EP1592437A4 Polymerized hemoglobin solutions having reduced amount of tetramer and method for preparing |
| 12/26/2007 | EP1565203A4 Templated native silk smectic gels |
| 12/26/2007 | EP1412384B1 Stable formulation of modified glp-1 |
| 12/26/2007 | EP1401869B1 Molecules and methods for inhibiting shedding of kim-1 |
| 12/26/2007 | EP1287024B1 Virulence genes, proteins, and their use |
| 12/26/2007 | EP1265914B1 Wnt-1 related polypeptides, and nucleic acids encoding the same |
| 12/26/2007 | EP1235596B1 Use of lytic toxins and toxin conjugates |
| 12/26/2007 | EP1177305B1 Method for producing a recombinant protein |
| 12/26/2007 | EP1116029B1 Apoptosis marker antibodies and methods of use |
| 12/26/2007 | EP1056778B1 G protein-coupled receptor antagonists |
| 12/26/2007 | EP0973895B1 Transcription factor islet-brain 1 (ib1) |
| 12/26/2007 | EP0877812B1 Antibodies and immunoglobulin fusion proteins having modified effector functions and uses therefor |
| 12/26/2007 | EP0862455B1 Interferon-polymer conjugates and process for preparing the same |
| 12/26/2007 | EP0778848B1 Agents for inducing apoptosis and applications of said agents in therapy |
| 12/26/2007 | EP0517829B2 Improved chimeric toxins |
| 12/26/2007 | CN101095053A Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84 |
| 12/26/2007 | CN101094921A Transgenic plants expressing intein modified proteins and associated processes for bio-pharmaceutical production |
| 12/26/2007 | CN101094919A Fungal transcriptional activators useful in methods for producing a polypeptide |
| 12/26/2007 | CN101094867A Method for solid phase peptide synthesis |
| 12/26/2007 | CN101094866A G protein coupled receptor agonists and antagonists and methods of use |
| 12/26/2007 | CN101094865A Modified growth hormones |
| 12/26/2007 | CN101094864A Purification of HER-2 variants |
| 12/26/2007 | CN101094863A Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest |
| 12/26/2007 | CN101094862A Hetero-oligomeric HIV envelope proteins |
| 12/26/2007 | CN101094688A Multimeric constructs |
| 12/26/2007 | CN101093221A Application of GADD45 ¿C beta protein and relevant cell factor in treating rheumatoid arthritis |
| 12/26/2007 | CN101092636A Selectively replicating viral vectors |
| 12/26/2007 | CN101092628A Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
| 12/26/2007 | CN101092627A Methods of screening for compounds that inhibit the biosynthesis of GPI in malaria parasites |
| 12/26/2007 | CN101092626A Gene of containing 26S rRNA sequence from restoring line of cotton |
| 12/26/2007 | CN101092623A Gene order of heat shock protein 90 of sugpo prawn |
| 12/26/2007 | CN101092616A Expressing and purifying neutrophilic granule protein NGP |
| 12/26/2007 | CN101092455A Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 12/26/2007 | CN101092454A Mutant gene Osnaat1-1 of rice rich in iron and zinc |
| 12/26/2007 | CN101092453A Therapeutic compounds comprised of anti-fc receptor binding agents |
| 12/26/2007 | CN101092452A Preparation method for both of micromolecule polypeptide of tumor chalone for anti angiogenesis, and fusion protein |
| 12/26/2007 | CN101092450A Heparinase polypeptide epitope combined to molecules in human MIIC ¿CI category |
| 12/26/2007 | CN101092448A Preparation method for separating and purifying water-soluble protein of ginseng |
| 12/26/2007 | CN100357443C Paramyxovirus vector encoding angiogenesis gene and utilization thereof |
| 12/26/2007 | CN100357442C Efficient fusion expression carrier |
| 12/26/2007 | CN100357438C Wheat seed hardness related gene and its encoding protein and uses |
| 12/26/2007 | CN100357437C Wheat seed hardness relative gene and its coded protein and use |
| 12/26/2007 | CN100357432C Waxy wheat starch types having waxy proteins in granule |
| 12/26/2007 | CN100357426C Culture and collection of dermatophagoides pteronyssinus and method for preparing its allergen diagnosis and treatment preparation |
| 12/26/2007 | CN100357324C Effectors of innate immunity |
| 12/26/2007 | CN100357323C Cell shifting related protein and its coding gene and application |
| 12/26/2007 | CN100357322C Disintegrating element for poisonous snake and its coding gene and use |
| 12/26/2007 | CN100357321C Stimulative phagocytizing factor and coded gene and application |
| 12/26/2007 | CN100357320C ZIBC gene and its coded protein and uses |
| 12/26/2007 | CN100357319C Barbadosnut cold-induced transcription factor, its encoding gene and uses |
| 12/26/2007 | CN100357318C Mermaid photobacterium envelop protein W and coding sequence , its preparation method and uses |
| 12/26/2007 | CN100357317C Pegylated T20 polypeptide |
| 12/26/2007 | CN100357314C Method for linking molecular substances |
| 12/26/2007 | CN100356978C Novel exendin agonist formulations and methods administration thereof |
| 12/26/2007 | CN100356853C Antimicrobial agent |
| 12/25/2007 | US7312375 Plant reproduction polynucleotides and methods of use |
| 12/25/2007 | US7312373 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 12/25/2007 | US7312333 N-heterocyclic hydroxyethylamine compounds; human immunodeficiency virus (HIV) protease |
| 12/25/2007 | US7312322 Genetic sequences encoding steroid and juvenile hormone receptor polypeptides and insecticidal modalities therefor |
| 12/25/2007 | US7312319 Neurotrophic factor (NT-4) immunoassay systems |
| 12/25/2007 | US7312317 P2Y4 antibodies |
| 12/25/2007 | US7312316 Novel polypeptides and nucleic acid molecules encoding those polypeptides; vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides fused to heterologous polypeptide sequences, and antibodies which bind to the polypeptides |
| 12/25/2007 | US7312315 PRO9742 antibodies |
| 12/25/2007 | US7312314 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 12/25/2007 | US7312313 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 12/25/2007 | US7312312 PRO6242 polypeptides |
| 12/25/2007 | US7312311 Attaching substances to microorganisms |
| 12/25/2007 | US7312310 PRO6015 polypeptides |
| 12/25/2007 | US7312309 For release of tumor necrosis and or cellular differentation/proliferation of chrondrocytes by contacting blood w/polypeptides; cancer diagnosis |
| 12/25/2007 | US7312308 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 12/25/2007 | US7312307 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 12/25/2007 | US7312304 Somatostatin agonists |
| 12/25/2007 | US7312303 Anti-PRO4980 antibodies |
| 12/25/2007 | US7312198 Protein compositions for promoting wound healing and skin regeneration |
| 12/25/2007 | US7312197 Method of modifying glucose activity using polypeptides selectively expressed in fat tissue |
| 12/25/2007 | US7312195 Pain, stroke, traumatic brain injury, blocking a voltage-sensitive calcium channel, blocking the nicotinic acetylcholine receptor; synthetic, has no free N- or C-terminus, cysteine residues bonded to form a disulfide bond |
| 12/25/2007 | US7312193 Calcium phosphopeptide complexes |
| 12/25/2007 | US7312192 For treating diseases including diabetes |
| 12/25/2007 | US7312190 Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 12/25/2007 | US7312089 Contacting biological sample with antibodies having specific binding affinity for erytrhopoetin receptor(EpoR), detecting presence, absence, or amount of EpoR by identifying the human blood progenitor cells having antibody bound thereto |
| 12/25/2007 | US7312086 Comprises nucleotide sequences coding membrane protein for diagnosis and treatment of nervous system, cancer, kidney, reproductive, inflammatory and metabolic disorders |
| 12/25/2007 | US7312081 Converting stem cell into ventral neuron for treatment of neurodegenerative and muscular disorders |
| 12/25/2007 | US7312080 Plant resistance to insect pests mediated by viral proteins |
| 12/25/2007 | US7312077 Insulin-secreting immortalized liver cell line modified by glucose sensitivity |
| 12/25/2007 | US7312076 Genetic engineered polypeptide binds to a pathogen; mucosal surface-colonizing; vaginas; HIV; Herpes |
| 12/25/2007 | US7312074 construct comprising a complex of a recombinant single-stranded polynucleotide and a chimeric protein produced in a host cell transformed with said recombinant polynucleotide and extruded therefrom without lysis of the host cell |
| 12/25/2007 | US7312066 Nucleic acid molecules encoding NRC interacting factor-1 (NIF-1) |
| 12/25/2007 | US7312064 Expression vector for use as transformation and gene expression tool in genetic engineering; minimum plasmid-based system for the generation of infectious RNA viruses, preferably influenza viruses, from cloned DNA |
| 12/25/2007 | US7312055 Hybrid enzymes |
| 12/25/2007 | US7312051 Polynucleotides encoding dendritic enriched secreted lymphocyte activation molecule |
| 12/25/2007 | US7312050 Nucleic acids encoding interphotoreceptor matrix proteins |
| 12/25/2007 | US7312041 Methods of diagnosing cervical cancer |
| 12/25/2007 | US7312032 Transgenic mammalian cells for use diagnostic tool in monitoring cell activities |
| 12/25/2007 | US7312030 Monitoring capability of genetically engineered arterivirus to propagate in cells; viricides; veterinary medicine; genetic vaccines |
| 12/25/2007 | US7312026 MRP-related ABC transporter encoding nucleic acids and methods of use thereof |
| 12/25/2007 | US7311922 comprising antigens and excipients, which increse serological sensitivity of individuals infected with tuberculosis; for use in diagnosis and prevention of tuberculosis infection |